HomeCompareHILS vs MRK

HILS vs MRK: Dividend Comparison 2026

HILS yields 843.88% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HILS wins by $4363248.74M in total portfolio value
10 years
HILS
HILS
● Live price
843.88%
Share price
$0.24
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4363248.80M
Annual income
$3,538,417,394,347.70
Full HILS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HILS vs MRK

📍 HILS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHILSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HILS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HILS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HILS
Annual income on $10K today (after 15% tax)
$71,729.96/yr
After 10yr DRIP, annual income (after tax)
$3,007,654,785,195.55/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HILS beats the other by $3,007,654,776,867.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HILS + MRK for your $10,000?

HILS: 50%MRK: 50%
100% MRK50/50100% HILS
Portfolio after 10yr
$2181624.43M
Annual income
$1,769,208,702,072.92/yr
Blended yield
81.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HILS
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-0.3
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HILS buys
0
MRK buys
0
No recent congressional trades found for HILS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHILSMRK
Forward yield843.88%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4363248.80M$56.8K
Annual income after 10y$3,538,417,394,347.70$9,798.13
Total dividends collected$4298592.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: HILS vs MRK ($10,000, DRIP)

YearHILS PortfolioHILS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$95,088$84,388.19$11,206$366.19+$83.9KHILS
2$851,681$749,936.40$12,650$502.35+$839.0KHILS
3$7,188,859$6,277,560.82$14,407$694.19+$7.17MHILS
4$57,213,181$49,521,101.51$16,585$967.82+$57.20MHILS
5$429,552,802$368,334,698.45$19,342$1,363.89+$429.53MHILS
6$3,044,138,048$2,584,516,550.07$22,913$1,947.19+$3044.12MHILS
7$20,374,845,574$17,117,617,861.98$27,662$2,823.89+$20374.82MHILS
8$128,876,441,910$107,075,357,146.57$34,159$4,173.35+$128876.41MHILS
9$770,870,472,639$632,972,679,795.13$43,337$6,308.80+$770870.43MHILS
10$4,363,248,800,072$3,538,417,394,347.70$56,776$9,798.13+$4363248.74MHILS

HILS vs MRK: Complete Analysis 2026

HILSStock

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6, which is also known to downregulate; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.

Full HILS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HILS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HILS vs SCHDHILS vs JEPIHILS vs OHILS vs KOHILS vs MAINHILS vs JNJHILS vs ABBVHILS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.